Ted Yednock

EVP & Chief Innovation Officer at Annexon Biosciences

No bio yet


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Annexon Biosciences

2 followers

Annexon is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye.